Delivery Order SPE2DB22D2007-SPE2DB24FJ6AS

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XULANE 150-35 MCG/DAY PATCH 3S. The $7,437.58 firm fixed price contract has an ultimate completion date of December 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a ceiling value of $2,788.35 and a period of performance through February 26, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a ceiling value of $2,445.50 and a performance period through May 23, 2025. The contract is a firm fixed-price delivery order, and is not set aside for any particular business type. Amerisourcebergen Drug Corp is the...
This is a $3,346.68 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XULANE 150-35 MCG/DAY PATCH 3S medical products. The contract has an ultimate completion date of November 5, 2024 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a ceiling value of $4,213.85 and a period of performance through March 11, 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription medication, with a ceiling value of $1,921.42 and a performance period ending on June 18, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. AmerisourceBergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,540.92 firm fixed-price contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The award has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,277.13, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a completion date of February 10, 2025 and is a Firm Fixed Price contract. This award is not associated with a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,624.20. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of June 21, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,474.20 firm fixed-price contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. The contract has an ultimate completion date of June 30, 2025 and is not designated as a set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ6AS
    Delivery Order

This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,015.05 firm fixed-price contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription medication, with a completion date of September 12, 2024. The contract is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 9/3/25, 9:57 AM